Company Active LTD

Company profile

Ncimb Limited

UK company SC078368, incorporated on 20 April 1982.

NCIMB | Microbiology | Analytical Services | Biomaterial Storage

Ncimb Limited is a UK company with status Active founded in 1982 based in Scotland.

Company number
SC078368
Incorporated
20 Apr 1982
Companies House status
Active

Company identity

Founded / incorporated
20 April 1982

Company number SC078368

Verify at Companies House
Legal name
NCIMB LIMITED
Company type
Private Limited Company
Region
Scotland
Registered address
WELLHEADS PLACE
DYCE
ABERDEEN
SCOTLAND
AB21 7GB
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

19 events
30 Apr
2027

Accounts due

Accounts Due

Next accounts due date

19 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

13 Aug
2026

Capital Variation Of Rights Attached To Shares

Capital

SH10 | Transaction MzUzODUxNzA5NmFkaXF6a2N4 | Paper/PDF filed

Published 18 Aug 2026 23:21

13 Aug
2026

Memorandum Articles

Incorporation

MA | Transaction MzUzODI4NjEwOGFkaXF6a2N4 | Paper/PDF filed

Published 13 Aug 2026 23:04

12 Aug
2026

Resolution

Resolution

RESOLUTIONS | Transaction WUY4QVI3WUFhZGlxemtjeA | Paper/PDF filed

Published 17 Aug 2026 22:45

11 Aug
2026

Mortgage Alter Floating Charge With Number

Mortgage

466(SCOT) | Transaction MzUzOTY4MzQ1NGFkaXF6a2N4 | Paper/PDF filed

Published 20 Aug 2026 23:22

11 Aug
2026

Mortgage Alter Floating Charge With Number

Mortgage

466(SCOT) | Transaction MzUzOTY4MzQ1M2FkaXF6a2N4 | Paper/PDF filed

Published 20 Aug 2026 23:02

08 Aug
2026

Mortgage Alter Floating Charge With Number

Mortgage

466(SCOT) | Transaction MzUzODUzNjE5NGFkaXF6a2N4 | Paper/PDF filed

Published 18 Aug 2026 22:58

07 Aug
2026

Mortgage Create With Deed With Charge Number Charge Creation Date

Mortgage

MR01 | Transaction MzUzNzUyMDAzMmFkaXF6a2N4

Published 07 Aug 2026 11:12

06 Aug
2026

Mortgage Create With Deed With Charge Number Charge Creation Date

Mortgage

MR01 | Transaction MzUzNzM0MjY0MmFkaXF6a2N4

Published 06 Aug 2026 14:50

31 Jul
2026

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzUzNjM0MTYzNWFkaXF6a2N4

Published 31 Jul 2026 14:45

10 Sep
2025

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQ4MDI0Njg4MmFkaXF6a2N4

Published 19 Aug 2026 14:11

05 Sep
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Jul
2025

Accounts filed

Accounts

Last accounts made up date

06 Jan
2023

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzM2NDgzOTczM2FkaXF6a2N4

Published 19 Aug 2026 14:11

19 Dec
2022

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzM2MjgzODE2OGFkaXF6a2N4

Published 19 Aug 2026 14:11

24 Aug
2004

Legacy

Address

287 | Transaction MTM2MTE5NzUxYWRpcXprY3g | Paper/PDF filed

Published 19 Aug 2026 14:11

24 Mar
2003

Legacy

Address

287 | Transaction MTA5NzU1NzIxYWRpcXprY3g | Paper/PDF filed

Published 19 Aug 2026 14:11

20 Apr
1982

Incorporated

Inception

Company registered at Companies House

Public funding

9 awards
First funded
2012
Funded years
2012, 2013, 2014, 2016, 2024
Age at first award
30 years

Projects

2024 Collaborative R&D Lead participant

Superior synbiotics for healthy ageing

1 Oct 2024 to 31 Mar 2026

Awarded
£87,556
Total cost £125,080

Scottish biotechnology company NCIMB, is teaming up with the Rowett Institute, University of Aberdeen to develop novel designer probiotics targeting gut health. NCIMB are microbiology experts and manage the UK's largest collection of bacterial strains. The Rowett Institute has expertise in the gut microbiome and the interactions between microbes and inter...

2024 Launchpad Lead participant

Development and Manufacture of Novel Cyclodextrins

1 May 2024 to 30 Apr 2025

Awarded
£99,763
Total cost £99,763

Cyclodextrins are cyclic oligosaccharides produced from starch hydrolysis using bacterial enzymes. They are safe, natural products that trap, solubilise, and stabilise a range of bioactive molecules. They are highly selective with applications in food, food supplements, personal care, pharmaceuticals, agrochemicals, paints, and surface coatings. The marke...

2024 Collaborative R&D Lead participant

Harnessing the power of engineering biology to develop and translate novel live biotherapeutics

1 Feb 2024 to 31 Jan 2025

Awarded
£136,662
Total cost £195,231

In this exciting collaborative project, NCIMB, an established Scottish biotechnology company, is teaming up with GitLife Biotech (GLB), a spinout from Newcastle University. The partners aim to develop new innovative products and services using groundbreaking Engineering Biology protocols. The proposed project centres around the development of a new class ...

2016 Feasibility Studies Lead participant

Neutralising the harmful effects of dental biofilms by bacterial replacement therapy

1 Jun 2016 to 31 May 2017

Awarded
£48,926
Total cost £69,894

Dental caries is a widespread oral disease that is costly for health services to treat, and causes pain and loss of teeth to those affected. It is caused by production of acid by oral bacteria in biofilms on the teeth and gums commonly known as dental plaque. Brushing teeth can reduce this problem, but many people do not do so regularly or thoroughly. Thi...

2016 Feasibility Studies Lead participant

Management and control of biofilms in the oil and gas industry

1 Mar 2016 to 28 Feb 2017

Awarded
£59,623
Total cost £85,176

Microbial biofilms can cause significant economic and environmental issues in oilfield systems from reduction in flow rates, souring of crude oil and contribution to corrosion of concrete and metal surfaces. Current methods for the control of biofilms in these situations include the use of chemical biocides which are expensive and can lead to environmenta...

2016 Knowledge Transfer Partnership

The Robert Gordon University and NCIMB Limited

1 Jan 2016 to 31 Dec 2018

Awarded
Unknown

To initiate exploitation of the NCIMB culture collection by developing knowledge and processes for screening Streptomyces sp. for novel natural commercial products and the development of new product lines.

2014 Feasibility Studies Lead participant

Identification of novel probiotic microorganisms for improved gut function

1 Jan 2014 to 31 Dec 2014

Awarded
£52,295
Total cost £69,727

Probiotics are live microorganisms which when taken in adequate amounts confer health benefits. Changing diets and lifestyles have seen an increase in diet-related health conditions which probiotics acting as novel functional food ingredients can help. There are many probiotic species but the majority of commercial products are restricted to the Lactobaci...

2013 Feasibility Studies Lead participant

Optimising energy production from anaerobic digestion using molecular microbial monitoring techniques developed for the oil and gas industries

1 Mar 2013 to 30 Jun 2013

Awarded
£12,764
Total cost £17,019

This feasibility study will investigate the potential of transferring competency and methods developed for use in the oil industry for the determination of bacterial populations, to the production of renewable energy from wastes and other renewable sources using anaerobic digestion (AD) technology. Improved performance and lowering of associated risks in ...

2012 Collaborative R&D

Accelerated development of industrial microbes using GSA

1 Sep 2012 to 31 Aug 2014

Awarded
£139,336
Total cost £278,672

This project addresses a severe limitation of the critical enabling technology required for the successful industrial use of engineered microbes, namely to rapidly achieve efficient production of proteins from heterologous DNA, either as end products in themselves or as enzymes whose concerted action produces other high value products. The project follows...

Product types

Collaborative R&D Feasibility Studies Knowledge Transfer Partnership Launchpad